Diagnostic Pathology of Early Systemic Cancer: ERBB2 Gene Amplification in Single Disseminated Cancer Cells Determines Patient Survival in Operable Esophageal Cancer

International Journal of Cancer - United States
doi 10.1002/ijc.31108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

HER2/neu (ERBB2) Expression and Gene Amplification Correlates With Better Survival in Esophageal Adenocarcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Detection of Disseminated Tumor Cells in Bone Marrow Predict Late Recurrences in Operable Breast Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Primary Systemic Therapy for Operable Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1991English

TP53 Status Determines Clinical Significance of ERBB2 Expression in Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2004English

Abnormal FHIT Gene Transcript and C-Myc and C-erbB2 Amplification in Breast Cancer.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2002English

Organ Preservation in Early Esophageal Cancer

Gastroenterology
HepatologyGastroenterology
2020English

Cancer Stem Cells in Esophageal Cancer and Response to Therapy

Cancer
Cancer ResearchOncology
2018English

Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-Her2 Agents in a Large Asian Cancer Patient Cohort

Frontiers in Oncology
Cancer ResearchOncology
2019English

RNAi-mediated ERBB2 Gene Knockdown Sensitizes Human Colorectal Cancer Cells to Radiation

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy